Application Information

This drug has been submitted to the FDA under the reference 207984/002.

Names and composition

"DABIGATRAN ETEXILATE" is the commercial name of a drug composed of DABIGATRAN ETEXILATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
207984/002 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 110MG
207984/003 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 150MG
208057/002 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 110MG
208057/003 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 150MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
207984/002 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 110MG
207984/003 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 150MG
208057/002 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 110MG
208057/003 DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE CAPSULE/ORAL 150MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved